Nevada Coalition for Psychedelic Medicines

Home
United States
Honolulu, HI
Nevada Coalition for Psychedelic Medicines

Saving Lives | Revolutionizing Mental Health The Nevada Coalition for Psychedelic Medicines is dedicated to healing through the use of psychedelic substances.

We strive to increase access to and understanding of these substances as potential therapies for mental health and well-being and to eliminate the stigma and criminalization associated with their use. Through collaboration, advocacy, and education, we aim to improve the health and lives of individuals in our state and nation.

09/16/2026

As the FDA marches toward the likely first approval of a psꪗchꫀdeꪶic medicine, the agency convened a hearing on September 14th seeking public input on how these drugs should be used, monitored and continuously studied in the real world.

The biggest question swirling around the hearing was one of access. Should a psꪗchꫀdeꪶic medicine be approved, who would the FDA allow to administer it? And how would that decision impact patients’ ability to actually receive the treatment?

NCPM President Jon Dalton testified before the FDA, bringing a distinctly Nevada perspective to the national conversation. He highlighted one of the most important barriers to equitable access: the shortage of qualified providers and clinical capacity in rural and frontier communities. Jon urged the FDA to preserve an appropriate role for trained non-physician clinicians and to develop product-specific safety requirements that reflect the realities of local healthcare systems.

Submit Written Comments:
Written comments must be submitted to the Federal Register : Considerations for Potential Future Therapeutic Use of Psꪗchꫀdeꪶic Drugs; Public Hearing; Request for Comments electronic filing system on or before 11:59 p.m. ET on October 5, 2026. Link in bio!

🛑18+ only. This content is for educational and harm-reduction purposes. We do not promote or support illegal activity, the sale or use of restricted substances, or the use of associated tools or accessories. Per Meta’s Community Standards, discussion of legality, research, and medical exploration is permitted. Not medical advice. Consult a qualified professional for health decisions.

09/15/2026

NCPM President Jon Dalton testified before the FDA regarding a critical barrier to access: workforce and clinic capacity in rural and frontier communities. Citing Nevada’s mental health provider shortage, he urged the FDA to preserve a role for appropriately trained non-physician clinicians and adopt product-specific safety requirements that reflect local healthcare resources.

Submit Written Comments:
Written comments must be submitted to the Federal Register: Considerations for Potential Future Therapeutic Use of P𝓈𝓎ched𝑒𝓁𝒾𝒸 Drugs; Public Hearing; Request for Comments electronic filing system on or before 11:59 p.m. ET on October 5, 2026. Link in bio!

🛑18+ only. This content is for educational and harm-reduction purposes. We do not promote or support illegal activity, the sale or use of restricted substances, or the use of associated tools or accessories. Per Meta’s Community Standards, discussion of legality, research, and medical exploration is permitted. Not medical advice. Consult a qualified professional for health decisions.

09/12/2026

On September 14, the FDA will hear directly from researchers, clinicians, patients, advocates, and the public about the future of psꪗchꫀdeꪶic medicines and psꪗchꫀdeꪶic-assisted therapies. Showing up matters because people deserve access to promising new treatments that are being studied for conditions where too many still suffer without adequate options. We can support rigorous science, strong safety standards, qualified therapists, responsible access, and patient choice - while making sure the voices of the people whose lives may be transformed by these therapies are heard.

NCPM President Jon Dalton will be in attendance, giving testimony in support of this important work and helping ensure that the voices of veterans, first responders, patients, practitioners, and advocates are part of this conversation. If you believe psꪗchꫀdeꪶic-assisted therapy deserves a fair, evidence-based path forward, this is a moment to show up and be counted.

Show up. Be informed. Add your voice. The future of healing is being shaped right now.

🗓️Date: September 14, 2026
⏰Time: 12:30 p.m. - 4:30 p.m. ET (9:30 am - 1:30 pm PST)
📍Meeting Location: Attend in Person or Online 💻Virtual: Via webcast 👥In Person: FDA’s White Oak Campus, Building 31, Room 1503 - Great Room 10903 New Hampshire Avenue, Silver Spring, Maryland 20993 FDA Campus Information (e.g., local airports, directions, and local hotels)

The links to register, to provide comment, and to watch live can all be found in our bio!

🛑18+ only. This content is for educational and harm-reduction purposes. We do not promote or support illegal activity, the sale or use of restricted substances, or the use of associated tools or accessories. Per Meta’s Community Standards, discussion of legality, research, and medical exploration is permitted. Not medical advice. Consult a qualified professional for health decisions.

09/10/2026

The week-long national convention of veterans and active-duty military support organization, The American Legion, came to an end on Sept. 4, with a major development. The organization adopted a resolution that backs the use of psꪗchꫀdeꪶic therapies to treat veterans and other members of the military who may be suffering from mental health conditions such as PTSD, depression or a traumatic brain injury.

Check out the full article:
https://www.military.com/american-legion-backs-psychedelic-therapies-for-veterans-with-ptsd-and-brain-injuries

🛑18+ only. This content is for educational and harm-reduction purposes. We do not promote or support illegal activity, the sale or use of restricted substances, or the use of associated tools or accessories. Per Meta’s Community Standards, discussion of legality, research, and medical exploration is permitted. Not medical advice. Consult a qualified professional for health decisions.

09/03/2026

The New Mexico Department of Health Center for Medical Cannabis and Ps𝒾𝓁𝑜cy𝒷𝒾𝓃 began accepting applications last week from potential producers to grow the mushrooms for future program participants. Cvitanovic told Source that the application is intended to ensure the ps𝒾𝓁𝑜cy𝒷𝒾𝓃 “produced for this program in New Mexico is both safe and medically beneficial for patients, as well as that this doesn’t cause safety issues for people in New Mexico generally.”

Check out the full article:
https://sfreporter.com/news/state-psilocybin-program-opens-permitting-applications-for-p/

🛑18+ only. This content is for educational and harm-reduction purposes. We do not promote or support illegal activity, the sale or use of restricted substances, or the use of associated tools or accessories. Per Meta’s Community Standards, discussion of legality, research, and medical exploration is permitted. Not medical advice. Consult a qualified professional for health decisions.

09/02/2026

Miller emphasized that receptor binding alone does not determine a compound’s clinical effect; the subsequent functional activity generated within the intracellular environment following that binding is equally central to understanding how ps𝒾𝓁𝑜cy𝒷𝒾𝓃, LᦓD, and 𝓂𝑒sca𝓁𝒾𝓃𝑒 ultimately produce their effects. He positioned this binding-to-function distinction as a key pharmacodynamic principle for clinicians to understand as psꪗchꫀdeꪶic compounds move closer to potential regulatory approval and broader clinical use.

Check out the full article:
https://www.psychiatrictimes.com/view/lessons-from-psychedelics-on-binding-and-functional-activity

🛑18+ only. This content is for educational and harm-reduction purposes. We do not promote or support illegal activity, the sale or use of restricted substances, or the use of associated tools or accessories. Per Meta’s Community Standards, discussion of legality, research, and medical exploration is permitted. Not medical advice. Consult a qualified professional for health decisions.

08/27/2026

The report published on Wednesday by the Substance Abuse and Mental Health Services Administration (SAMHSA) says that substances such as ps𝒾𝓁𝑜cy𝒷𝒾𝓃, LᦓD and M𝐷M𝐴 “show potential in clinical studies for treating depression, post-traumatic stress disorder, anxiety, and substance use disorders,” though it cautions that the evidence base “remains uneven and important methodological limitations persist.”

The SAMHSA report notes that President Donald Trump issued an executive order aimed at expanding and expediting research on the potential therapeutic benefits of psꪗchꫀdeꪶics in April with an eye toward federal approval of psꪗchꫀdeꪶic medications by the Food and Drug Administration (FDA).

State officials should “consider planning now for the fiscal, legal, and operational implications of potential FDA-approved psꪗchꫀdeꪶic therapies, including any Medicaid coverage obligations,” it says.

Check out the full article:
https://www.marijuanamoment.net/states-should-start-planning-now-for-fda-approval-of-psychedelics-federal-report-says/

🛑18+ only. This content is for educational and harm-reduction purposes. We do not promote or support illegal activity, the sale or use of restricted substances, or the use of associated tools or accessories. Per Meta’s Community Standards, discussion of legality, research, and medical exploration is permitted. Not medical advice. Consult a qualified professional for health decisions.

08/25/2026

While adjustment disorder can develop in response to a range of life events, the study focuses on people whose symptoms occur in the context of a serious medical illness.

The study is being led by Anthony Rothschild, MD, the Irving S. and Betty Brudnick Chair in Psychiatry and professor of psychiatry & behavioral sciences, and brings together clinicians and researchers across multiple departments, including psychiatry, medicine and neurology.

Check out the full article:
UMass Chan researchers study psychedelic medication for adjustment disorder in people with serious medical conditions

🛑18+ only. This content is for educational and harm-reduction purposes. We do not promote or support illegal activity, the sale or use of restricted substances, or the use of associated tools or accessories. Per Meta’s Community Standards, discussion of legality, research, and medical exploration is permitted. Not medical advice. Consult a qualified professional for health decisions.

08/24/2026

Nevada is at a pivotal moment as lawmakers consider how to responsibly bring psꪗchꫀdeꪶic-assisted therapies into the state’s healthcare system. The legislation discussed in the article reflects a growing effort to move beyond the long-standing stigma surrounding psꪗchꫀdeꪶics while establishing guardrails for research, clinical use and patient safety. The goal is not simply to make these substances available, but to create a framework grounded in evidence and responsible medical practice as research continues to develop.

UNLV neuroscientist Dustin Hines brings that scientific caution to the conversation. Hines has emphasized that psꪗchꫀdeꪶics show significant therapeutic promise, but that researchers are still working to understand precisely how they affect the brain, who is most likely to benefit and under what conditions they can be used safely. His work underscores an important distinction: promising results are not the same as a complete scientific understanding. For Hines, continued research is essential to turning the potential of psꪗchꫀdeꪶics into treatments that are evidence-based, safe and clinically effective.

Check out the full article here:
https://lasvegasweekly.com/news/2026/aug/20/psychedelics-could-offer-a-lifeline-for-nevada/

🛑18+ only. This content is for educational and harm-reduction purposes. We do not promote or support illegal activity, the sale or use of restricted substances, or the use of associated tools or accessories. Per Meta’s Community Standards, discussion of legality, research, and medical exploration is permitted. Not medical advice. Consult a qualified professional for health decisions.

08/20/2026

The announcement of the hearing was made a day after FDA issued the long-awaited finalized guidance on “Psꪗchꫀdeꪶic Drugs: Considerations for Clinical Investigations” providing recommendations to sponsors on clinical trial design for this class of drugs.

Key Details:
Stakeholders across the pharmaceutical, healthcare, research, and investment sectors, as well as the broader medical community, should be aware of the following key details regarding the hearing:  Public Hearing:
* Date: September 14, 2026, from 12:30 p.m. to 4:30 p.m. ET
* Format: Hybrid (in-person and virtual webcast)

Critical Deadlines:
* Requests to Present Oral Comments: August 21, 2026, by 11:59 p.m. ET
* Written Comment Submission Deadline: October 5, 2026, by 11:59 p.m. ET
Written comments may be submitted electronically via regulations.gov.

Topics for Public Input:
FDA and its federal agency partners are seeking input on the potential future therapeutic use of psꪗchꫀdeꪶic drugs in supervised and supportive settings, organized around four key areas:
1. Provider training and credentialing
2. Promotion of patient safety
3. Considerations for access
4. Best practices for data collection and standardization

Check out the full article for more guidance:
https://foleyhoag.com/news-and-insights/publications/alerts-and-updates/2026/august/psychedelic-therapeutics-take-center-stage-fda-announces-public-hearing-and-finalizes-clinical/

🛑18+ only. This content is for educational and harm-reduction purposes. We do not promote or support illegal activity, the sale or use of restricted substances, or the use of associated tools or accessories. Per Meta’s Community Standards, discussion of legality, research, and medical exploration is permitted. Not medical advice. Consult a qualified professional for health decisions.

Address

415 S Beretania St
Honolulu, HI
96813

Website

https://www.nevadacpm.org/

Alerts

Be the first to know and let us send you an email when Nevada Coalition for Psychedelic Medicines posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The School

Send a message to Nevada Coalition for Psychedelic Medicines:

Featured

Quantum School of Massage & Holistic Health
931 University Avenue

Want your school to be the top-listed School/college in Honolulu?